<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39447322</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1545-1151</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>24</Day></PubDate></JournalIssue><Title>Preventing chronic disease</Title><ISOAbbreviation>Prev Chronic Dis</ISOAbbreviation></Journal><ArticleTitle>Moving Diabetes Prevention Programs to the Workplace: A Qualitative Exploration of Barriers and Facilitators to Participant Engagement When Implemented by an Employer-Based Clinic.</ArticleTitle><Pagination><StartPage>E83</StartPage><MedlinePgn>E83</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">E83</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5888/pcd21.240173</ELocationID><Abstract><AbstractText Label="PURPOSE AND OBJECTIVES" NlmCategory="UNASSIGNED">The Diabetes Prevention Program (DPP), an effective evidence-based strategy to reduce the incidence of type 2 diabetes, has been widely implemented in various locations, including workplaces. However, most people do not remain engaged in the program for the recommended full year. Limited qualitative research exists around participant engagement in the workplace DPP. Our study aimed to explore participant engagement in the DPP delivered through the employer-based clinic (EBC) at a large technology company.</AbstractText><AbstractText Label="INTERVENTION APPROACH" NlmCategory="UNASSIGNED">The DPP was implemented through the EBC at a large technology company in Southern California, beginning in September 2019 by using in-person and virtual synchronous group classes before and during the COVID-19 pandemic.</AbstractText><AbstractText Label="EVALUATION METHODS" NlmCategory="UNASSIGNED">Virtual focus groups with DPP participants from 2 inaugural cohorts were conducted via Zoom from October 2020 to February 2021. Data were analyzed by using inductive thematic analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Five focus groups with 2 to 3 participants in each (total n = 12) were conducted, 2 focus groups per cohort and 1 focus group with the group instructors. Barriers and facilitators to engagement in the DPP were grouped into thematic domains: Individual Drivers, Small Group Community, Workplace Setting, Integrated EBC, and the COVID-19 Pandemic. Results showed that prepandemic workplace demands (ie, meetings, travel) affected DPP participation, yet the group setting provided social support in the workplace to engage in and maintain healthy habits. With the move to a virtual synchronous offering during the pandemic, participants valued the group setting but expressed a preference for in-person meetings. Collectively, participant engagement was bolstered by shared buy-in and collaboration between the employer and the EBC.</AbstractText><AbstractText Label="IMPLICATIONS FOR PUBLIC HEALTH" NlmCategory="UNASSIGNED">Our findings suggest that engagement in a workplace DPP can be supported by addressing workplace-specific barriers and gaining buy-in from employers. Delivering the DPP, in person and virtually, through an EBC has the potential to engage employees who have prediabetes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Sandra A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>211 Quarry Road, MC 5987, Stanford, CA 94304 (sandra.tsai@stanford.edu).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacker</LastName><ForeName>Alexandria</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Jonathan G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown-Johnson</LastName><ForeName>Cati</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Prev Chronic Dis</MedlineTA><NlmUniqueID>101205018</NlmUniqueID><ISSNLinking>1545-1151</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017132" MajorTopicYN="Y">Workplace</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017144" MajorTopicYN="Y">Focus Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="Y">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006293" MajorTopicYN="N">Health Promotion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002140" MajorTopicYN="N" Type="Geographic">California</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009786" MajorTopicYN="N">Occupational Health Services</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>18</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39447322</ArticleId><ArticleId IdType="pmc">PMC11505923</ArticleId><ArticleId IdType="doi">10.5888/pcd21.240173</ArticleId><ArticleId IdType="pii">E83</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. 10.1056/NEJMoa012512</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa012512</ArticleId><ArticleId IdType="pmc">PMC1370926</ArticleId><ArticleId IdType="pubmed">11832527</ArticleId></ArticleIdList></Reference><Reference><Citation>Albright AL, Gregg EW. Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program. Am J Prev Med. 2013;44(4 suppl 4):S346–S351. 10.1016/j.amepre.2012.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2012.12.009</ArticleId><ArticleId IdType="pmc">PMC4539613</ArticleId><ArticleId IdType="pubmed">23498297</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention. Diabetes Prevention Recognition Program application. Registry of all recognized organizations. 2024. Accessed September 23, 2024. https://dprp.cdc.gov/Registry
</Citation></Reference><Reference><Citation>Brown SA, García AA, Zuñiga JA, Lewis KA. Effectiveness of workplace diabetes prevention programs: A systematic review of the evidence. Patient Educ Couns. 2018;101(6):1036–1050. 10.1016/j.pec.2018.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2018.01.001</ArticleId><ArticleId IdType="pubmed">29339040</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakkalakal RJ, Connor LR, Rolando LA, Huang Y, Byrne DW, Awalt BM, et al.. Putting the National Diabetes Prevention Program to work: Predictors of achieving weight-loss goals in an employee population. Prev Chronic Dis. 2019;16(9):E125. 10.5888/pcd16.190053</Citation><ArticleIdList><ArticleId IdType="doi">10.5888/pcd16.190053</ArticleId><ArticleId IdType="pmc">PMC6818132</ArticleId><ArticleId IdType="pubmed">31517599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely EK, Gruss SM, Luman ET, Gregg EW, Ali MK, Nhim K, et al.. A national effort to prevent type 2 diabetes: participant-level evaluation of CDC’s National Diabetes Prevention Program. Diabetes Care. 2017;40(10):1331–1341. 10.2337/dc16-2099</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc16-2099</ArticleId><ArticleId IdType="pmc">PMC5606310</ArticleId><ArticleId IdType="pubmed">28500215</ArticleId></ArticleIdList></Reference><Reference><Citation>Giese KK, Cook PF. Reducing obesity among employees of a manufacturing plant: translating the Diabetes Prevention Program to the workplace. Workplace Health Saf. 2014;62(4):136–141. 10.1177/216507991406200402</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/216507991406200402</ArticleId><ArticleId IdType="pubmed">24702680</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3(11):866–875. 10.1016/S2213-8587(15)00291-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(15)00291-0</ArticleId><ArticleId IdType="pmc">PMC4623946</ArticleId><ArticleId IdType="pubmed">26377054</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafez D, Fedewa A, Moran M, O’Brien M, Ackermann R, Kullgren JT. Workplace interventions to prevent type 2 diabetes mellitus: a narrative review. Curr Diab Rep. 2017;17(2):9. 10.1007/s11892-017-0840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-017-0840-0</ArticleId><ArticleId IdType="pmc">PMC5669619</ArticleId><ArticleId IdType="pubmed">28150162</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention. Information for employers and insurers. 2023. Accessed March 24, 2024. 
https://www.cdc.gov/diabetes-prevention/employers-insurers/index.html
</Citation></Reference><Reference><Citation>
Umland B. Employers launch worksite clinics despite ACA uncertainty. 2015. Accessed June 30, 2024. 
https://www.mercer.com/en-us/insights/us-health-news/employers-launch-worksite-clinics-despite-aca-uncertainty/
</Citation></Reference><Reference><Citation>Lord DJ, Wright JR, Fung R, Lederhaus ES, Taylor K, Watts SA, et al.. Integrated physical medicine at employer-sponsored health clinics improves quality of care at reduced cost. J Occup Environ Med. 2019;61(5):382–390. 10.1097/JOM.0000000000001536</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JOM.0000000000001536</ArticleId><ArticleId IdType="pubmed">30640844</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahly V, Kessler RC, Duncan I. Worksite primary care clinics: a systematic review. Popul Health Manag. 2014;17(5):306–315. 10.1089/pop.2013.0095</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/pop.2013.0095</ArticleId><ArticleId IdType="pubmed">24835541</ArticleId></ArticleIdList></Reference><Reference><Citation>
Grensing-Pophal L. Is an on-site health clinic right for your company? 2024. Accessed June 30, 2024. 
https://www.shrm.org/topics-tools/news/benefits-compensation/is-an-onsite-health-clinic-right-for-your-company-
</Citation></Reference><Reference><Citation>Hennink M, Hutter I, Bailey A. Qualitative research methods. 2nd edition. Sage Publications, Inc; 2020.</Citation></Reference><Reference><Citation>Creswell JW, Poth CN. Qualitative inquiry and research design: choosing from among the five approaches. Fourth edition. Sage Publications, Inc; 2017.</Citation></Reference><Reference><Citation>Borek AJ, Abraham C, Greaves CJ, Tarrant M, Garner N, Pascale M. ‘We’re all in the same boat’: a qualitative study on how groups work in a diabetes prevention and management programme. Br J Health Psychol. 2019;24(4):787–805. 10.1111/bjhp.12379</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjhp.12379</ArticleId><ArticleId IdType="pubmed">31273908</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison CR, Phimphasone-Brady P, DiOrio B, Raghuanath SG, Bright R, Ritchie ND, et al.. Barriers and facilitators of National Diabetes Prevention Program engagement among women of childbearing age: a qualitative study. Diabetes Educ. 2020;46(3):279–288. 10.1177/0145721720920252</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0145721720920252</ArticleId><ArticleId IdType="pubmed">32597384</ArticleId></ArticleIdList></Reference><Reference><Citation>Baucom KJW, Pershing ML, Dwenger KM, Karasawa M, Cohan JN, Ozanne EM. Barriers and facilitators to enrollment and retention in the National Diabetes Prevention Program: perspectives of women and clinicians within a health system. Womens Health Rep (New Rochelle). 2021;2(1):133–141. 10.1089/whr.2020.0102</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/whr.2020.0102</ArticleId><ArticleId IdType="pmc">PMC8139255</ArticleId><ArticleId IdType="pubmed">34036296</ArticleId></ArticleIdList></Reference><Reference><Citation>Joachim-Célestin M, Gamboa-Maldonado T, Dos Santos H, Montgomery SB. A qualitative study on the perspectives of Latinas enrolled in a Diabetes Prevention Program: is the cost of prevention too high? J Prim Care Community Health. 2020;11:2150132720945423. 10.1177/2150132720945423</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2150132720945423</ArticleId><ArticleId IdType="pmc">PMC7543125</ArticleId><ArticleId IdType="pubmed">32755275</ArticleId></ArticleIdList></Reference><Reference><Citation>Golovaty I, Wadhwa S, Fisher L, Lobach I, Crowe B, Levi R, et al.. Reach, engagement and effectiveness of in-person and online lifestyle change programs to prevent diabetes. BMC Public Health. 2021;21(1):1314. 10.1186/s12889-021-11378-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11378-4</ArticleId><ArticleId IdType="pmc">PMC8256225</ArticleId><ArticleId IdType="pubmed">34225674</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>